The results showed that cancer types expressing RSK2 at the highest rate compared to the other RSK family members were bladder carcinoma, breast tumor, colorectal tumor, esophageal tumor, liver tumor, prostate tumor, skin tumor, and uterine tumor (Supplementary Figure S4a). Here, RPS6KA2 is linked to colorectal neoplasm.